Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 57
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Femoral neck cortical bone distribution in Nacholapithecus from the Middle Miocene of Kenya

  • Tomizawa, Yuma
  • Pina, Marta|||0000-0001-9762-6402
  • Kikuchi, Yasuhiro|||0000-0002-0336-5609
  • Morimoto, Naoki|||0000-0002-8367-4777
  • Nakatsukasa, Masato|||0000-0002-6897-8027
Nacholapithecus kerioi from the Middle Miocene (16-15 Ma) of the Aka Aitheputh Formation in Kenya is represented by abundant postcranial fossils. Their morphology suggests that the body plan of N. kerioi was similar to that of primitive apes, which do not specialize in suspensory locomotion, and that this taxon generally engaged in arboreal quadrupedalism (Nakatsukasa et al., 1998, 2007; Ishida et al., 2004; Nakatsukasa and Kunimatsu, 2009; Almécija et al., 2021; Pina et al., 2021; Pina and Nakatsukasa, 2024). However, some forelimb features suggest a derived locomotor pattern indicative of incipient forelimb dominance (Nakatsukasa et al., 1998, 2004, 2007, 2012; Ishida et al., 2004; Takano et al., 2018, 2020). For example, KNM-BG 35250 has a bulbous and rounded humeral capitulum, which contributes to the stabilization of the elbow during protonation/supination movements (Ishida et al., 2004; Takano et al., 2018). Overall, N. kerioi may have mainly relied on cautious arboreal quadrupedalism, occasionally engaging in some kind(s) of antipronograde locomotor mode(s).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration

  • Giralt, Lena
  • Figueras-Roca, Marc|||0000-0002-0548-0539
  • Eguileor, Beatriz De Luis
  • Romero, Barbara
  • Zarranz-Ventura, Javier|||0000-0003-2338-8143
  • Alforja, Socorro
  • Santiago, Francisca
  • Bolaños, Jennifer
  • Lozano, Francisco
  • Dotti-Boada, Marina
  • Sala-Puigdollers, Anna
  • Dura, Paula
  • Izquierdo-Serra, Jordi
  • Valero, Oliver|||0000-0003-0014-9916
  • Adan Civera, Alfredo|||0000-0002-0849-8814
  • Fonollosa, Alex
  • Molins, Blanca|||0000-0003-0941-9134
To determine and compare the serum levels of complement Factor H (FH), monomeric C-Reactive Protein (mCRP) and pentameric C-Reactive protein (pCRP) in patients with age-related macular degeneration (AMD) and to correlate them with clinical, structural and functional parameters. Cross-sectional observational study. One hundred thirty-nine individuals (88 patients and 51 healthy controls) from two referral centers were included and classified into three groups: early or intermediate AMD (n=33), advanced AMD (n=55), and age and sex matched healthy controls (n=51). Serum levels of FH, mCRP, and pCRP were determined and correlated with clinical and imaging parameters. Patients with intermediate AMD presented FH levels significantly lower than controls [186.5 (72.1-931.8) µg/mL vs 415.2 (106.1-1962.2) µg/mL; p=0.039] and FH levels <200 µg/mL were associated with the presence of drusen and pigmentary changes in the fundoscopy (p=0.002). While no differences were observed in pCRP and mCRP levels, and mCRP was only detected in less than 15% of the included participants, women had a significantly higher detection rate of mCRP than men (21.0% vs. 3.8%, p=0.045). In addition, the ratio mCRP/FH (log) was significantly lower in the control group compared to intermediate AMD (p=0.031). Visual acuity (p<0.001), macular volume (p<0.001), and foveal thickness (p=0.034) were significantly lower in the advanced AMD group, and choroidal thickness was significantly lower in advanced AMD compared to early/intermediate AMD (p=0.023). Intermediate AMD was associated in our cohort with decreased serum FH levels together with increased serum mCRP/FH ratio. All these objective serum biomarkers may suggest an underlying systemic inflammatory process in early/intermediate AMD patients.
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

Latency Fairness Optimization on Wireless Networks Through Deep Reinforcement Learning

  • López-Sánchez, María
  • Villena-Rodríguez, Alejandro
  • Gómez-Paredes, Gerardo
  • Martín-Vega, Francisco-Javier
  • Aguayo-Torres, María del Carmen
https://openpolicyfinder.jisc.ac.uk/id/publication/3582, In this paper, we propose a novel deep reinforcement learning (DRL) framework to maximize user fairness in terms of delay. To this end, we devise a new version of the modified largest weighted delay first (M-LWDF) algorithm, called β-M-LWDF, aiming to fulfill an appropriate balance between user fairness and average delay. This balance is defined as a feasible region on the cumulative distribution function (CDF) of the user delay that allows identifying unfair states, feasible-fair states, and over-fair states. Simulation results reveal that our proposed framework outperforms traditional resource allocation techniques in terms of latency fairness and average delay., Unión Europea, Junta de Andalucía, Universidad de Málaga, Agencia Estatal de Investigación
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

A Physical Layer Multicast Precoding and Grouping Scheme for Bandwidth Minimization.

  • Martín-Vega, Francisco Javier
  • Rostami Ghadi, Farshad
  • López-Martínez, Francisco Javier
  • Gómez-Paredes, Gerardo
Physical layer multicasting exploits multiple antennas at the transmitter side to deliver a common message to a group of K users. To this end, two formulations have been well addressed in the literature: i) the max-min-fair criterion, which maximizes the signal-to-noise ratio (SNR) of the worst user for a fixed transmit power; and ii) the quality of service (QoS) formulation, which minimizes the transmit power subject to a target SNR. Nevertheless, it is known that the performance and complexity of these approaches is severely degraded as the group size grows. In this paper, we propose a different formulation that aims at minimizing the required bandwidth needed to provide the multicast service. This is achieved by dividing the users into smaller groups and assigning the bandwidth required to provide a target rate to each group. Contrary to the common belief, it is shown that dividing the users into different groups that use orthogonal bandwidth allocations can lead to a smaller aggregated bandwidth than the single-group with single bandwidth allocation counterpart, if an intelligent grouping scheme is used. An iterative algorithm to derive the optimal number of groups is presented with an stopping criterion to reduce the numerical complexity. It is shown through simulation that our proposed approach greatly reduces the required bandwidth compared to existing schemes that rely on single bandwidth allocation. Interestingly, results reveal that our proposed scheme also leads to a greater SNR for a randomly chosen user, and it reduces the variance of the required bandwidth, which eases the implementation in real networks., Unión Europea, Junta de Andalucía, Universidad de Málaga
Repisalud
Publication Artículo científico (JournalArticle)

Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project

  • Dierssen-Sotos, Trinidad
  • Palazuelos-Calderón, Camilo
  • Jimenez-Moleon, Jose J.
  • Aragones, Nuria
  • Altzibar, Jone M
  • Castaño-Vinyals, Gemma
  • Martín-Sánchez, Vicente
  • Gómez-Acebo, Inés
  • Guevara, Marcela
  • Tardón, Adonina
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Moreno, Victor
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno-Iribas, Conchi
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: Reproductive factors are well known risk factors for breast cancer; however, little is known about how genetic variants in hormonal pathways interact with that relationship. METHODS: One thousand one hundred thirty nine cases of breast cancer in women and 1322 frequency-matched controls were compared. Genetic variants in hormonal pathways (identified in the Kyoto Encyclopedia of Genes and Genomes) were screened according to their relationship with breast cancer using the Cochran-Armitage statistic. Information on reproductive factors was obtained using a face-to-face questionnaire. The interaction among the selected genetic variants and reproductive factors was tested with logistic regression. RESULTS: Concerning C allele in rs2229712, compared to nulliparity in non-carriers the ORs for 1-2 and > 2 deliveries were 0.48 (0.28-0.81) and 0.34 (0.19-0.59), and in C carriers they were 0.92 (0.42-1.98) and 0.71 (0.31-1.61). Similar results were found in women carrying the C allele in rs1269851. Carriers of Allele T in rs35652107 and allele C in rs6018027 had the delivery number effect more pronounced. CONCLUSIONS: The number of deliveries had a dose-response protective effect on breast cancer; women carrying C allele in rs2229712 did not benefit from this protective effect.
Repisalud
Publication Artículo científico (JournalArticle)

Low adherence to the western and high adherence to the mediterranean dietary patterns could prevent colorectal cancer

  • Castelló Pastor, Adela
  • Amiano, Pilar
  • Fernandez de Larrea-Baz, Nerea
  • Martín, Vicente
  • Alonso, María Henar
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Olmedo-Requena, Rocío
  • Guevara, Marcela
  • Fernández-Tardón, Guillermo
  • Dierssen-Sotos, Trinidad
  • Llorens-Ivorra, Cristóbal
  • Huerta, José María
  • Capelo, Rocío
  • Fernández-Villa, Tania
  • Díez-Villanueva, Anna
  • Urtiaga, Carmen
  • Castilla Catalán, Jesús
  • Jimenez-Moleon, Jose J.
  • Moreno, Victor
  • Dávila-Batista, Verónica
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
PURPOSE: To assess if the associations found between three previously identified dietary patterns with breast, prostate and gastric cancer are also observed for colorectal cancer (CRC). METHODS: MCC-Spain is a multicase-control study that collected information of 1629 incident cases of CRC and 3509 population-based controls from 11 Spanish provinces. Western, Prudent and Mediterranean data-driven dietary patterns-derived in another Spanish case-control study-were reconstructed in MCC-Spain. Their association with CRC was assessed using mixed multivariable logistic regression models considering a possible interaction with sex. Risk by tumor site (proximal colon, distal colon, and rectum) was evaluated using multinomial regression models. RESULTS: While no effect of the Prudent pattern on CRC risk was observed, a high adherence to the Western dietary pattern was associated with increased CRC risk for both males [ORfourth(Q4) vs. first(Q1)quartile (95% CI): 1.45 (1.11;1.91)] and females [ORQ4 vs. Q1 (95% CI): 1.50 (1.07;2.09)] but seem to be confined to distal colon [ORfourth(Q4) vs. first(Q1)quartile (95% CI): 2.02 (1.44;2.84)] and rectal [ORQ4 vs. Q1 (95% CI): 1.46 (1.05;2.01)] tumors. The protective effect of the Mediterranean dietary pattern against CRC was observed for both sexes [males: ORQ4 vs. Q1 (95% CI): 0.71 (0.55;0.92); females: ORQ4 vs. Q1 (95% CI): 0.56 (0.40;0.77)] and for all cancer sites: proximal colon [ORQ4 vs. Q1 (95% CI): 0.70 (0.51;0.97)], distal colon [ORQ4 vs. Q1 (95% CI): 0.65 (0.48;0.89)], and rectum (ORQ4 vs. Q1 (95% CI): 0.60 (0.45;0.81)]. CONCLUSION: Our results are consistent with most of the associations previously found between these patterns and breast, prostate and gastric cancer risk and indicate that consuming whole fruits, vegetables, legumes, olive oil, nuts, and fish and avoiding red and processed meat, refined grains, sweets, caloric drinks, juices, convenience food, and sauces might reduce CRC risk.
Repisalud
Publication Artículo científico (JournalArticle)

Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Vilorio-Marqués, Laura
  • Gracia, Esther
  • Aragones, Nuria
  • Olmedo-Requena, Rocío
  • Llorca, Javier
  • Vidán, Juana
  • Amiano, Pilar
  • Nos, Pilar
  • Fernández-Tardón, Guillermo
  • Rada, Ricardo
  • Chirlaque, María-Dolores
  • Guinó, Elisabet
  • Dávila-Batista, Verónica
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Mirón-Pozo, Benito
  • Dierssen-Sotos, Trinidad
  • Etxeberria, Jaione
  • Molinuevo, Amaia
  • Álvarez-Cuenllas, Begoña
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Moreno, Victor
A safe and effective colorectal cancer (CRC) chemoprevention agent remains to be discovered. We aim to evaluate the association between the use of glucosamine and/or chondroitin sulphate and risk of colorectal cancer (CRC) in the MCC-Spain study, a case-control study performed in Spain that included 2140 cases of CRC and 3950 population controls. Subjects were interviewed on sociodemographic factors, lifestyle, family and medical history and regular drug use. Adjusted odds ratios and their 95% confidence intervals were estimated. The reported frequency of chondroitin and/or glucosamine use was 2.03% in controls and 0.89% in cases. Users had a reduced risk of CRC (OR: 0.47; 95% CI: 0.28-0.79), but it was no longer significant when adjusted for NSAID (nonsteroidal anti-inflammatory drugs) use (OR: 0.82; 95% CI: 0.47-1.40). A meta-analysis with previous studies suggested a protective effect, overall and stratified by NSAID use (OR: 0.77; 95% CI: 0.62-0.97). We have not found strong evidence of an independent preventive effect of CG on CRC in our population because the observed effects of our study could be attributed to NSAIDs concurrent use. These results merit further research due to the safety profile of these drugs.
Repisalud
Publication Artículo científico (JournalArticle)

Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study

  • Vallès, Xavier
  • Alonso, María Henar
  • López-Caleya, Juan Francisco
  • Díez-Obrero, Virginia
  • Dierssen-Sotos, Trinidad
  • Lope Carvajal, Virginia
  • Molina-Barceló, Ana
  • Chirlaque, María Dolores
  • Jimenez-Moleon, Jose J.
  • Fernández Tardón, Guillermo
  • Castilla Catalán, Jesús
  • Amiano, Pilar
  • Capelo, Rocío
  • Castaño-Vinyals, Gemma
  • Guinó, Elisabet
  • Molina de la Torre, Antonio José
  • Moreno-Iribas, Conchi
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Llorca, Javier
  • Martín, Vicente
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Moreno, Victor
OBJECTIVES: To explore the association of colorectal cancer with environmental solar radiation and sun exposure behavior, considering phenotypic variables (eye color, hair color and skin phenotype), dietary intake of vitamin D and calcium, and socio-demographic factors. STUDY DESIGN: Multicenter population-based frequency matched case-control study in Spain (MCC-Spain), with 2140 CRC cases and 3950 controls. METHODS: Data were obtained through personal interviews using a structured epidemiological questionnaire that included socio-demographic data, residential history, environmental exposures, behavior, phenotypic and dietary information. An environmental-lifetime sun exposure score was constructed combining residential history and average daily solar radiation, direct and diffuse. Logistic regression was used to explore the association between different variables. A structural equation model was used to verify the associations of the conceptual model. RESULTS: We found a lower risk of CRC in subjects frequently exposed to sunlight during the previous summer and skin burning due to sun exposure. No association was observed in relation to the residential solar radiation scores. Subjects with light eye or light hair colors had a lower risk of CRC that those with darker colors. Dietary calcium and vitamin D were also protective factors, but not in the multivariate model. The structural equation model analysis suggested that higher sun exposure was associated with a decreased risk of CRC, as well as dietary intake of calcium and vitamin D, and these factors are correlated among themselves and with environmental solar radiation and skin phenotypes. CONCLUSION: The results agree with previous observations that sun exposure, dietary vitamin D and calcium intake, and serum 25(OH)D concentration reduce the risk of CRC and indicate that these factors may be relevant for cancer prevention.
Repisalud
Publication Artículo científico (JournalArticle)

Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study)

  • Garcia-Saenz, Ariadna
  • Sánchez de Miguel, Alejandro
  • Espinosa, Ana
  • Valentin, Antonia
  • Aragones, Nuria
  • Llorca, Javier
  • Amiano, Pilar
  • Martín Sánchez, Vicente
  • Guevara, Marcela
  • Capelo, Rocío
  • Tardón, Adonina
  • Peiró-Pérez, Rosana
  • Jimenez-Moleon, Jose J.
  • Roca-Barceló, Aina
  • Perez-Gomez, Beatriz
  • Dierssen-Sotos, Trinidad
  • Fernández-Villa, Tania
  • Moreno-Iribas, Conchi
  • Moreno, Victor
  • García-Pérez, Javier
  • Castaño-Vinyals, Gemma
  • Pollan-Santamaria, Marina
  • Aubé, Martin
  • Kogevinas, Manolis
BACKGROUND: Night shift work, exposure to light at night (ALAN) and circadian disruption may increase the risk of hormone-dependent cancers. OBJECTIVES: We evaluated the association of exposure to ALAN during sleeping time with breast and prostate cancer in a population based multicase-control study (MCC-Spain), among subjects who had never worked at night. We evaluated chronotype, a characteristic that may relate to adaptation to light at night. METHODS: We enrolled 1,219 breast cancer cases, 1,385 female controls, 623 prostate cancer cases, and 879 male controls from 11 Spanish regions in 2008-2013. Indoor ALAN information was obtained through questionnaires. Outdoor ALAN was analyzed using images from the International Space Station (ISS) available for Barcelona and Madrid for 2012-2013, including data of remotely sensed upward light intensity and blue light spectrum information for each geocoded longest residence of each MCC-Spain subject. RESULTS: Among Barcelona and Madrid participants with information on both indoor and outdoor ALAN, exposure to outdoor ALAN in the blue light spectrum was associated with breast cancer [adjusted odds ratio (OR) for highest vs. lowest tertile, OR=1.47; 95% CI: 1.00, 2.17] and prostate cancer (OR=2.05; 95% CI: 1.38, 3.03). In contrast, those exposed to the highest versus lowest intensity of outdoor ALAN were more likely to be controls than cases, particularly for prostate cancer. Compared with those who reported sleeping in total darkness, men who slept in "quite illuminated" bedrooms had a higher risk of prostate cancer (OR=2.79; 95% CI: 1.55, 5.04), whereas women had a slightly lower risk of breast cancer (OR=0.77; 95% CI: 0.39, 1.51). CONCLUSION: Both prostate and breast cancer were associated with high estimated exposure to outdoor ALAN in the blue-enriched light spectrum. https://doi.org/10.1289/EHP1837.
Repisalud
Publication Artículo científico (JournalArticle)

Validating a breast cancer score in Spanish women. The MCC-Spain study

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Palazuelos, Camilo
  • Fernandez-Navarro, Pablo L
  • Altzibar, Jone M
  • González-Donquiles, Carmen
  • Ardanaz, Eva
  • Bustamante, Mariona
  • Alonso-Molero, Jéssica
  • Vidal, Carmen
  • Bayo-Calero, Juan
  • Tardón, Adonina
  • Salas, Dolores
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Rodríguez-Cundín, Paz
  • Vinyals, Gemma Castaño
  • Ederra, María
  • Vilorio-Marqués, Laura
  • Amiano, Pilar
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
Repisalud
Publication Artículo científico (JournalArticle)

Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study

  • Huerta, José María
  • Chirlaque, María-Dolores
  • Molina, Antonio J
  • Amiano, Pilar
  • Martín, Vicente
  • Fernández-Villa, Tania
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Burgui, Rosana
  • Gómez-Acebo, Inés
  • Ramos-Lora, Manuel
  • Fernández-Tardón, Guillermo
  • Peiró, Rosana
  • Olmedo-Requena, Rocío
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
BACKGROUND: Evidence for a protective role of physical activity against development of stomach cancer is yet inconclusive. We studied the association of domain-specific physical activity and the risk of gastric adenocarcinoma (GAC), by site and histology, in the MCC-Spain case-control study. METHODS: 428 histologically confirmed GAC cases (67% men) including the gastro-esophageal region and 3225 controls were included. Cases were recruited in hospitals from 10 different Spanish regions, whereas population controls were randomly selected within the respective hospitals' catchment areas. A physical activity (PA) questionnaire was used to gather information on household and recreational activities, allowing estimation of PA volume (in metabolic equivalents (MET)-min/week). Participants also reported the intensity of working PA and daily sitting time. Questionnaire data on diet, lifestyles and clinical variables including Helicobacter pylori serology were available. Adjusted odds ratios (OR) of GAC were estimated for domains of physical activity, stratifying by sex, site (cardia vs. non-cardia), and Lauren classification (intestinal vs. diffuse). RESULTS: Household physical activity (HPA) showed a strong inverse association with GAC, observed for both cardia and non-cardia tumours. Risk of overall gastric cancer was 50% lower risk among participants in the highest HPA category (OR = 0.50, 95%CI: 0.38, 0.66). Recreational physical activity (RPA) was also associated with lower overall GAC risk (OR = 0.68, 95% CI: 0.52, 0.88), particularly at moderate levels of intensity such as walking (OR = 0.61, 95% CI: 0.46, 0.79). The protective effect of RPA was strongest for non-cardia tumours. Sedentary time was not related to GAC risk (p-trend = 0.392), but the potential protective effect of RPA was restricted to non-sedentary participants. CONCLUSIONS: Both household and recreational physical activities were independently related to lower GAC risk in the MCC-Spain study.
Repisalud
Publication Artículo científico (JournalArticle)

Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain

  • Rubín-García, María
  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Aragones, Nuria
  • Adarnaz, Eva
  • Castaño-Vinyals, Gemma
  • Obón-Santacana, Mireia
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Fernández-Tardón, Guillermo
  • Jimenez-Moleon, Jose J.
  • Alguacil, Juan
  • Chirlaque, María-Dolores
  • Toledo, Estefanía
  • Perez-Gomez, Beatriz
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Several anticancer properties have been largely attributed to phenolics in in vivo and in vitro studies, but epidemiologic evidence is still scarce. Furthermore, some classes have not been studied in relation to gastric cancer (GC). The aim of this study was to assess the relationship between the intake of phenolic acids, stilbenes, and other phenolics and the risk of developing GC and its anatomical and histological subtypes. We used data from a multi-case-control study (MCC-Spain) obtained from different regions of Spain. We included 2700 controls and 329 GC cases. Odds ratios (ORs) were calculated using mixed effects logistic regression considering quartiles of phenolic intake. Our results showed an inverse association between stilbene and lignan intake and GC risk (ORQ4 vs. Q1 = 0.47; 95% CI: 0.32-0.69 and ORQ4 vs. Q1 = 0.53; 95% CI: 0.36-0.77, respectively). We found no overall association between total phenolic acid and other polyphenol class intake and GC risk. However, hydroxybenzaldehydes (ORQ4 vs. Q1 = 0.41; 95% CI: 0.28-0.61), hydroxycoumarins (ORQ4 vs. Q1 = 0.49; 95% CI: 0.34-0.71), and tyrosols (ORQ4 vs. Q1 = 0.56; 95% CI: 0.39-0.80) were inversely associated with GC risk. No differences were found in the analysis by anatomical or histological subtypes. In conclusion, a diet high in stilbenes, lignans, hydroxybenzaldehydes, hydroxycoumarins, and tyrosols was associated with a lower GC risk. Further prospective studies are needed to confirm our results.
Repisalud
Publication Artículo científico (JournalArticle)

Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain)

  • García-Pérez, Javier
  • Lope Carvajal, Virginia
  • Perez-Gomez, Beatriz
  • Molina, Antonio José
  • Tardón, Adonina
  • Díaz Santos, María Angustias
  • Ardanaz, Eva
  • O'Callaghan-Gordo, Cristina
  • Altzibar, Jone M
  • Gómez-Acebo, Inés
  • Moreno, Victor
  • Peiró, Rosana
  • Marcos-Gragera, Rafael
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Lopez-Abente, Gonzalo
  • Pollan-Santamaria, Marina
Breast cancer is the most frequent tumor in women worldwide, although well-established risk factors account for 53%-55% of cases. Therefore, other risk factors, including environmental exposures, may explain the remaining variation. Our objective was to assess the relationship between risk of breast cancer and residential proximity to industries, according to categories of industrial groups and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Using the current residence of cases and controls, this study was restricted to small administrative divisions, including both breast cancer cases (452) and controls (1511) in the 10 geographical areas recruiting breast cancer cases. Distances were calculated from the respective woman's residences to the 116 industries located in the study area. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (between 1 km and 3 km) to industrial plants, adjusting for matching variables and other confounders. Excess risk (OR; 95%CI) of breast cancer was found near industries overall (1.30; 1.00-1.69 at 3 km), particularly organic chemical industry (2.12; 1.20-3.76 at 2.5 km), food/beverage sector (1.87; 1.26-2.78 at 3 km), ceramic (4.71; 1.62-13.66 at 1.5 km), surface treatment with organic solvents (2.00; 1.23-3.24 at 3 km), and surface treatment of plastic and metals (1.51; 1.06-2.14 at 3 km). By pollutants, the excess risk (OR; 95%CI) was detected near industries releasing pesticides (2.09; 1.14-3.82 at 2 km), and dichloromethane (2.09; 1.28-3.40 at 3 km). Our results suggest a possible increased risk of breast cancer in women living near specific industrial plants and support the need for more detailed exposure assessment of certain agents released by these plants.
Repisalud
Publication Artículo científico (JournalArticle)

Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Palazuelos, Camilo
  • Fernandez-Navarro, Pablo L
  • Castaño-Vinyals, Gemma
  • Alonso-Molero, Jéssica
  • Urtiaga, Carmen
  • Fernández-Villa, Tania
  • Ardanaz, Eva
  • Rivas-Del-Fresno, Manuel
  • Molina-Barceló, Ana
  • Jimenez-Moleon, Jose J.
  • García-Martínez, Lidia
  • Amiano, Pilar
  • Rodríguez-Cundín, Paz
  • Moreno, Victor
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
INTRODUCTION: Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal. METHODS: We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype-cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer. RESULTS: The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate. CONCLUSIONS: Phototype is not associated with breast or prostate cancer.
Repisalud
Publication Artículo científico (JournalArticle)

Validation of self-reported perception of proximity to industrial facilities: MCC-Spain study

  • Castelló Pastor, Adela
  • Perez-Gomez, Beatriz
  • Lora-Pablos, David
  • Lope Carvajal, Virginia
  • Castaño-Vinyals, Gemma
  • Vitelli-Storelli, Facundo
  • Dierssen-Sotos, Trinidad
  • Amiano, Pilar
  • Guevara, Marcela
  • Moreno, Victor
  • Lozano-Lorca, Macarena
  • Tardón, Adonina
  • Alguacil, Juan
  • Hernández-García, Marta
  • Marcos-Gragera, Rafael
  • Chirlaque López, María Dolores
  • Ardanaz, Eva
  • Ibarluzea, Jesús
  • Gómez-Acebo, Inés
  • Molina, Antonio J
  • O'Callaghan-Gordo, Cristina
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • García-Pérez, Javier
BACKGROUND: Self-reported data about environmental exposures can lead to measurement error. OBJECTIVES: To validate the self-reported perception of proximity to industrial facilities. METHODS: MCC-Spain is a population-based multicase-control study of cancer in Spain that recruited incident cases of breast, colorectal, prostate, and stomach cancer. The participant's current residence and the location of the industries were geocoded, and the linear distance between them was calculated (gold standard). The epidemiological questionnaire included a question to determine whether the participants perceived the presence of any industry at ≤1 km from their residences. Sensitivity and specificity of individuals' perception of proximity to industries were estimated as measures of classification accuracy, and the area under the curve (AUC) and adjusted odds ratios (aORs) of misclassification were calculated as measures of discrimination. Analyses were performed for all cases and controls, and by tumor location, educational level, sex, industrial sector, and length of residence. Finally, aORs of cancer associated with real and self-reported distances were calculated to explore differences in the estimation of risk between these measures. RESULTS: Sensitivity of the questionnaire was limited (0.48) whereas specificity was excellent (0.89). AUC was sufficient (0.68). Participants with breast (aOR(95%CI) = 2.03 (1.67;2.46)), colorectal (aOR(95%CI) = 1.41 (1.20;1.64)) and stomach (aOR(95%CI) = 1.59 (1.20;2.10)) cancer showed higher risk of misclassification than controls. This risk was higher for lower educational levels (aOR<primaryvs.university (95%CI) = 1.78 (1.44;2.20)), among younger participants (aOR22-54 yearsvs. 73-85 years (95%CI) = 1.32 (1.09;1.60)), and for some industrial sectors: pharmaceutical (aOR(95%CI) = 29.02 (19.52;43.14)), galvanization (aOR(95%CI) = 14.14 (6.78;29.47)), and ceramic (aOR(95%CI) = 12.73 (7.22;22.44)). Participants living ≤1 year in the study area showed a lower risk of misclassification ((aOR≤1vs.>15 years (95%CI) = 0.56 (0.36;0.85)). The use of self-reported proximity vs. real distance to industrial facilities biased the effect on cancer risk towards the nullity. CONCLUSIONS: Self-reported distance to industrial facilities can be a useful tool for hypothesis generation, but hypothesis-testing studies should use real distance to report valid conclusions. The sensitivity of the question might be improved with a more specific formulation.
Repisalud
Publication Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Fernandez-Navarro, Pablo L
  • Palazuelos, Camilo
  • Moreno, Victor
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Jimenez-Moleon, Jose J.
  • Ruiz-Cerdá, Jose Luis
  • Perez-Gomez, Beatriz
  • Ruiz-Dominguez, José Manuel
  • Molero, Jessica Alonso
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Repisalud
Publication Artículo científico (JournalArticle)

Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)

  • Pinto-Carbó, M
  • Peiró-Pérez, R
  • Molina-Barceló, Ana
  • Vanaclocha-Espi, Mercedes
  • Alguacil, Juan
  • Castaño-Vinyals, Gemma
  • O'Callaghan-Gordo, Cristina
  • Gràcia-Lavedan, Esther
  • Perez-Gomez, Beatriz
  • Lope Carvajal, Virginia
  • Aragones, Nuria
  • Molina, A J
  • Fernández-Villa, Tania
  • Gil-Majuelo, L
  • Amiano, P
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Guevara, M
  • Moreno-Iribas, C
  • Obón-Santacana, Mireia
  • Rodríguez-Suárez, M M
  • Salcedo-Bellido, I
  • Delgado-Parrilla, A
  • Marcos-Gragera, R
  • Chirlaque, María-Dolores
  • Kogevinas, M
  • Pollan-Santamaria, Marina
  • Salas, D
There is evidence for the influence of socioeconomic status (SES) on healthy behaviours but the effect of social mobility (SM) is not yet well known. This study aims to analyse the influence of origin and destination SES (O-SES and D-SES) and SM on healthy behaviours and co-occurrence, from an integrated gender and age perspective. Data were obtained from the controls of MCC-Spain between 2008-2013 (3,606 participants). Healthy behaviours considered: healthy diet, moderate alcohol consumption, non-smoking and physical activity. SM was categorized as stable high, upward, stable medium, downward or stable low. Binary and multinomial logistic regression models were adjusted. Those aged <65, with a low O-SES, D-SES and stable low SM are less likely to have healthy behaviours in the case of both women (physically active: OR = 0.65 CI = 0.45-0.94, OR = 0.71 CI = 0.52-0.98, OR = 0.61 CI = 0.41-0.91) and men (non-smokers: OR = 0.44 CI = 0.26-0.76, OR = 0.54 CI = 0.35-0.83, OR = 0.41 CI 0.24-0.72; physically active: OR = 0.57 CI = 0.35-0.92, OR = 0.64 CI = 0.44-0.95, OR = 0.53 CI = 0.23-0.87). However, for those aged ≥65, this probability is higher in women with a low O-SES and D-SES (non-smoker: OR = 8.09 CI = 4.18-15.67, OR = 4.14 CI = 2.28-7.52; moderate alcohol consumption: OR = 3.00 CI = 1.45-6.24, OR = 2.83 CI = 1.49-5.37) and in men with a stable low SM (physically active: OR = 1.52 CI = 1.02-1.26). In the case of men, the same behaviour pattern is observed in those with a low O-SES as those with upward mobility, with a higher probability of co-occurring behaviours (three-to-four behaviours: OR = 2.00 CI = 1.22-3.29; OR = 3.13 CI = 1.31-7.48). The relationship of O-SES, D-SES and SM with healthy behaviours is complex and differs according to age and gender.
Repisalud
Publication Artículo científico (JournalArticle)

Cohort profile: the MCC-Spain follow-up on colorectal, breast and prostate cancers: study design and initial results

  • Alonso-Molero, Jéssica
  • Molina, Antonio J
  • Jimenez-Moleon, Jose J.
  • Perez-Gomez, Beatriz
  • Martín, Vicente
  • Moreno, Victor
  • Amiano, Pilar
  • Ardanaz, Eva
  • de Sanjose, Silvia
  • Salcedo, Inmaculada
  • Fernández-Tardón, Guillermo
  • Alguacil, Juan
  • Salas, Dolores
  • Marcos-Gragera, Rafael
  • Chirlaque, María-Dolores
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
PURPOSE: Since 2016, the multicase-control study in Spain (MCC-Spain) has focused towards the identification of factors associated with cancer prognosis. Inception cohorts of patients with colorectal, breast and prostate cancers were assembled using the incident cases originally recruited. PARTICIPANTS: 2140 new cases of colorectal cancer, 1732 of breast cancer and 1112 of prostate cancer were initially recruited in 12 Spanish provinces; all cancers were incident and pathologically confirmed. Follow-up was obtained for 2097 (98%), 1685 (97%) and 1055 (94.9%) patients, respectively. FINDINGS TO DATE: Information gathered at recruitment included sociodemographic factors, medical history, lifestyle and environmental exposures. Biological samples were obtained, and 80% of patients were genotyped using a commercial exome array. The follow-up was performed by (1) reviewing medical records; (2) interviewing the patients by phone on quality of life; and (3) verifying vital status and cause of death in the Spanish National Death Index. Ninety-seven per cent of recruited patients were successfully followed up in 2017 or 2018; patient-years of follow-up were 30 914. Most colorectal cancers (52%) were at clinical stage II or lower at recruitment; 819 patients died in the follow-up and the 5-year survival was better for women (74.4%) than men (70.0%). 71% of breast cancers were diagnosed at stages I or II; 206 women with breast cancer died in the follow-up and the 5-year survival was 90.7%. 49% of prostate cancers were diagnosed at stage II and 32% at stage III; 119 patients with prostate cancer died in the follow-up and the 5-year survival was 93.7%. FUTURE PLANS: MCC-Spain has built three prospective cohorts on highly frequent cancers across Spain, allowing to investigate socioeconomic, clinical, lifestyle, environmental and genetic variables as putative prognosis factors determining survival of patients of the three cancers and the inter-relationship of these factors.
Repisalud
Publication Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • de Pedro, María
  • Perez-Gomez, Beatriz
  • Servitja, Sonia
  • Moreno, Victor
  • Amiano, Pilar
  • Fernandez-Villa, Tania
  • Barricarte, Aurelio
  • Tardón, Adonina
  • Diaz-Santos, Marian
  • Peiró-Pérez, Rosana
  • Marcos-Gragera, Rafael
  • Lope Carvajal, Virginia
  • Gràcia-Lavedan, Esther
  • Alonso, María Henar
  • Michelena-Echeveste, Maria Jesus
  • Garcia-Palomo, Andrés
  • Guevara, Marcela
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
BACKGROUND: The relationship between non-steroidal antiinflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). METHODS: In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. RESULTS: In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. CONCLUSION: Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers.
Repisalud
Publication Artículo científico (JournalArticle)

Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Riera-Ponsati, Marina
  • Fernández-Villa, Tania
  • Fernandez-Navarro, Pablo L
  • Bustamante, Mariona
  • Llorca, Javier
  • Amiano, Pilar
  • Ascunce, Nieves
  • Fernández-Tardón, Guillermo
  • Salcedo Bellido, Inmaculada
  • Salas, Dolores
  • Capelo Álvarez, Rocío
  • Crous-Bou, Marta
  • Ortega-Valín, Luis
  • Perez-Gomez, Beatriz
  • Castaño-Vinyals, Gemma
  • Palazuelos, Camilo
  • Altzibar, Jone M
  • Ardanaz, Eva
  • Tardón, Adonina
  • Jimenez-Moleon, Jose J.
  • Olmos Juste, Valle
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Moreno, Victor
Dyslipidemia and statin use have been associated with colorectal cancer (CRC), but prospective studies have shown mixed results. We aimed to determine whether dyslipidemia is causally linked to CRC risk using a Mendelian randomization approach and to explore the association of statins with CRC. A case-control study was performed including 1336 CRC cases and 2744 controls (MCC-Spain). Subjects were administered an epidemiological questionnaire and were genotyped with an array which included polymorphisms associated with blood lipids levels, selected to avoid pleiotropy. Four genetic lipid scores specific for triglycerides (TG), high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), or total cholesterol (TC) were created as the count of risk alleles. The genetic lipid scores were not associated with CRC. The ORs per 10 risk alleles, were for TG 0.91 (95%CI: 0.72-1.16, p = 0.44), for HDL 1.14 (95%CI: 0.95-1.37, p = 0.16), for LDL 0.97 (95%CI: 0.81-1.16, p = 0.73), and for TC 0.98 (95%CI: 0.84-1.17, p = 0.88). The LDL and TC genetic risk scores were associated with statin use, but not the HDL or TG. Statin use, overall, was a non-significant protective factor for CRC (OR 0.84; 95%CI: 0.70-1.01, p = 0.060), but lipophilic statins were associated with a CRC risk reduction (OR 0.78; 95%CI 0.66-0.96, p = 0.018). Using the Mendelian randomization approach, our study does not support the hypothesis that lipid levels are associated with the risk of CRC. This study does not rule out, however, a possible protective effect of statins in CRC by a mechanism unrelated to lipid levels.
Repisalud
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publication Artículo científico (JournalArticle)

Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)

  • Obón-Santacana, Mireia
  • Romaguera, Dora
  • Gràcia-Lavedan, Esther
  • Molinuevo, Amaia
  • Molina-Montes, Esther
  • Shivappa, Nitin
  • Hebert, James R
  • Tardón, Adonina
  • Castaño-Vinyals, Gemma
  • Moratalla, Ferran
  • Guinó, Elisabet
  • Marcos-Gragera, Rafael
  • Azpiri, Mikel
  • Gil, Leire
  • Olmedo-Requena, Rocío
  • Lozano-Lorca, Macarena
  • Alguacil, Juan
  • Fernández-Villa, Tania
  • Martín, Vicente
  • Molina, Antonio J
  • Ederra, María
  • Moreno-Iribas, Conchi
  • Perez-Gomez, Beatriz
  • Aragones, Nuria
  • Castelló Pastor, Adela
  • Huerta, José María
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Molina-Barceló, Ana
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Moreno, Victor
  • Amiano, Pilar
Inflammation and antioxidant capacity have been associated with colorectal and breast cancer. We computed the dietary inflammatory index (DII®), and the total dietary non-enzymatic antioxidant capacity (NEAC) and associated them with colorectal and breast cancer risk in the population-based multi case-control study in Spain (MCC-Spain). We included 1852 colorectal cancer and 1567 breast cancer cases, and 3447 and 1486 population controls, respectively. DII score and NEAC were derived using data from a semi-quantitative validated food frequency questionnaire. Unconditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) for energy-adjusted DII (E-DII), and a score combining E-DII and NEAC. E-DII was associated with colorectal cancer risk (OR = 1.93, highest quartile versus lowest, 95%CI:1.60-2.32; p-trend: <0.001); this increase was observed for both colon and rectal cancer. Less pronounced increased risks were observed for breast cancer (OR = 1.22, highest quartile versus lowest, 95%CI:0.99-1.52, p-trend: >0.10). The combined score of high E-DII scores and low antioxidant values were associated with colorectal cancer risk (OR = 1.48, highest quartile versus lowest, 95%CI: 1.26-1.74; p-trend: <0.001), but not breast cancer. This study provides evidence that a pro-inflammatory diet is associated with increased colorectal cancer risk while findings for breast cancer were less consistent.
Repisalud
Publication Artículo científico (JournalArticle)

Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Mirones, Mónica
  • Perez-Gomez, Beatriz
  • Guevara, Marcela
  • Amiano, Pilar
  • Sala, María
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno, Victor
  • Suarez-Calleja, Claudia
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Marcos-Gragera, Rafael
  • Fernández-Ortiz, María
  • Sanz-Guadarrama, Oscar
  • Castaño-Vinyals, Gemma
  • Gil-Majuelo, Leire
  • Moreno-Iribas, Conchi
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
The St Gallen Conference endorsed in 2013 a series of recommendations on early breast cancer treatment. The main purpose of this article is to ascertain the clinical factors associated with St Gallen-2013 recommendations accomplishment. A cohort of 1152 breast cancer cases diagnosed with pathological stage < 3 in Spain between 2008 and 2013 was begun and then followed-up until 2017/2018. Data on patient and tumour characteristics were obtained from medical records, as well as their first line treatment. First line treatments were classified in three categories, according on whether they included the main St Gallen-2013 recommendations, more than those recommended or less than those recommended. Multinomial logistic regression models were carried out to identify factors associated with this classification and Weibull regression models were used to find out the relationship between this classification and survival. About half of the patients were treated according to St Gallen recommendations; 21% were treated over what was recommended and 33% received less treatment than recommended. Factors associated with treatment over the recommendations were stage II (relative risk ratio [RRR] = 4.2, 2.9-5.9), cancer positive to either progesterone (RRR = 8.1, 4.4-14.9) or oestrogen receptors (RRR = 5.7, 3.0-11.0). Instead, factors associated with lower probability of treatment over the recommendations were age (RRR = 0.7 each 10 years, 0.6-0.8), poor differentiation (RRR = 0.09, 0.04-0.19), HER2 positive (RRR = 0.46, 0.26-0.81) and triple negative cancer (RRR = 0.03, 0.01-0.11). Patients treated less than what was recommended in St Gallen had cancers in stage 0 (RRR = 21.6, 7.2-64.5), poorly differentiated (RRR = 1.9, 1.2-2.9), HER2 positive (RRR = 3.4, 2.4-4.9) and luminal B-like subtype (RRR = 3.6, 2.6-5.1). Women over 65 years old had a higher probability of being treated less than what was recommended if they had luminal B-like, HER2 or triple negative cancer. Treatment over St Gallen was associated with younger women and less severe cancers, while treatment under St Gallen was associated with older women, more severe cancers and cancers expressing HER2 receptors.
Repisalud
Publication Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Perez-Gomez, Beatriz
  • Gómez-Acebo, Inés
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio J
  • Salas-Trejo, Dolores
  • Fernández-Tardón, Guillermo
  • Lope Carvajal, Virginia
  • Jimenez-Moleon, Jose J.
  • Marcos-Gragera, Rafael
  • Dierssen-Sotos, Trinidad
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela
  • Fernández-Villa, Tania
  • Molina-Barceló, Ana
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Castaño-Vinyals, Gemma
  • Alguacil, Juan
  • Kogevinas, Manolis
  • de Sanjose, Silvia
  • Costas, Laura
BACKGROUND: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. OBJECTIVES: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. METHODS: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. RESULTS: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. CONCLUSIONS: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Repisalud
Publication Artículo científico (JournalArticle)

Agreement among Mediterranean Diet Pattern Adherence Indexes: MCC-Spain Study

  • Olmedo-Requena, Rocío
  • González-Donquiles, Carmen
  • Dávila-Batista, Verónica
  • Romaguera, Dora
  • Castelló Pastor, Adela
  • Molina de la Torre, Antonio José
  • Amiano, Pilar
  • Dierssen-Sotos, Trinidad
  • Guevara, Marcela
  • Fernández-Tardón, Guillermo
  • Lozano-Lorca, Macarena
  • Alguacil, Juan
  • Peiró, Rosana
  • Huerta, José María
  • Gràcia-Lavedan, Esther
  • Aragones, Nuria
  • Fernández-Villa, Tania
  • Solans, Marta
  • Gómez-Acebo, Inés
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Martín, Vicente
There are many different methods used to measure the degree of adherence to a Mediterranean diet (MD), limiting comparison and interpretation of their results. The concordance between different methodologies has been questioned and their evaluation recommended. The aim of this study was to evaluate the agreement among five indexes that measure adherence to a Mediterranean dietary pattern. The study population included healthy adults selected in the Multi-Case Control Spain (MCC-Spain) study recruited in 12 provinces. A total of 3640 controls were matched to cases by age and sex. To reach the aim, the following scores of adherence to a Mediterranean dietary pattern were calculated: Mediterranean diet score (MDS), alternative Mediterranean diet (aMED), relative Mediterranean diet (rMED), dietary score (DS) and literature-based adherence score (LBAS). The relative frequency of subjects with a high level of adherence to a MD varied from 22% (aMED index) to 37.2% (DS index). Similarly, a high variability was observed for the prevalence of a low level of MD: from 24% (rMED) to 38.4% (aMED). The correlation among MDS, aMED and rMED indexes was moderate, except for MDS and aMED with a high coefficient of correlation 0.75 (95% CI 0.74⁻0.77). The Cohen's Kappa coefficient among indexes showed a moderate⁻fair concordance, except for MDS and aMED with a 0.56 (95% CI 0.55⁻0.59) and 0.67 (95% CI 0.66⁻0.68) using linear and quadratic weighting, respectively. The existing MD adherence indexes measured the same, although they were based on different constructing algorithms and varied in the food groups included, leading to a different classification of subjects. Therefore, concordance between these indexes was moderate or low.
Repisalud
Publication Artículo científico (JournalArticle)

Dietary Constituents: Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Gutiérrez-Ruiz, Nuria
  • Aragones, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela
  • Alonso-Molero, Jéssica
  • Obón-Santacana, Mireia
  • Fernández-Tardón, Guillermo
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Marcos-Gragera, Rafael
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma
  • Canseco Fernandez, Rosario
  • Castilla Catalán, Jesús
  • Molinuevo, Amaia
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p-trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Repisalud
Publication Artículo científico (JournalArticle)

Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors

  • Marcos-Delgado, Alba
  • Martín-Sánchez, Vicente
  • Molina-Barceló, Ana
  • Alonso-Molero, Jéssica
  • Perez-Gomez, Beatriz
  • Pollán, Marina
  • Aragones, Nuria
  • Ederra-Sanz, María
  • Fernández-Tardón, Guillermo
  • Binefa, Gemma
  • Moreno, Victor
  • Barrios-Rodríguez, Rocío
  • Amiano, Pilar
  • Huerta, José María
  • Teso, Enrique Pastor
  • Alguacil, Juan
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • Molina de la Torre, Antonio José
The aim of our study is to evaluate the relationship between sociodemographic and clinical characteristics of individuals with Colorectal Cancer (CRC), tumour-intrinsic characteristics and treatment received with health-related quality of life (HRQoL). Methods: Cross-sectional analysis of data from 805 survivors from the MCC study was conducted. HRQoL was assessed through a general and specific questionnaire, SF-12 and FCSI (Colorectal Symptom Index). Statistical analyses were performed with linear regression with adjustment for sociodemographic variables, stage at diagnosis and histological grade. Results: Participants had survived a median of 7.9 years from diagnosis (IQR 7.1-8.5 years). Age at diagnosis, sex and area showed a clear association with HRQoL in both physical and mental dimensions of the SF-12 questionnaire. A direct association between CRC recurrence was also found in the PCS-12 and MCS-12 dimensions and radical surgery in the PCS-12. Regarding the scores in FCSI questionnaire, statistically significant differences were observed by sex, age and area, with older women being the most impaired (p < 0.001). Conclusions: Age, sex and area was associated with lower scores of HRQoL among CRC survivors. Knowing the determinants related to HRQoL would allow us to lay the groundwork to develop strategies that help reduce morbidity and mortality, relapses and increase HRQoL.
Repisalud
Publication Artículo científico (JournalArticle)

Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer

  • Butt, Julia
  • Fernandez de Larrea-Baz, Nerea
  • Tjalsma, Harold
  • Roelofs, Rian
  • Kato, Ikuko
  • Martín, Vicente
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Dierssen-Sotos, Trinidad
  • Castilla Catalán, Jesús
  • Fernández-Tardón, Guillermo
  • Amiano, Pilar
  • Salas, Dolores
  • Alguacil, Juan
  • Jimenez-Moleon, Jose J.
  • Huerta, José María
  • de Sanjose, Silvia
  • Del Campo, Rosa
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Pawlita, Michael
  • Waterboer, Tim
  • Boleij, Annemarie
  • Aragones, Nuria
Antibodies to Streptococcus gallolyticus subspecies gallolyticus (SGG) have been associated with colorectal cancer (CRC). Because SGG may correlate with impaired gut epithelia, we assessed the association of antibodies to bacterial flagellin C (FliC), a measure potentially related to this impairment, with CRC and the CRC-specific interaction with antibodies to SGG proteins. Antibodies to FliC and SGG pilus proteins Gallo2178 and Gallo2179 were measured in two independent studies, a combined study from Nijmegen and Detroit (93 CRC cases, 74 controls) and a replication data set including 576 cases and 576 controls from the Spanish multicenter multicase-control study (MCC-Spain). Logistic regression was applied to assess whether antibodies to FliC were associated with CRC and modified the association of antibodies to SGG proteins with CRC. Antibodies to FliC were associated with those to SGG Gallo2178 among CRC cases, resulting in an interaction in the association of antibodies to Gallo2178 with CRC (p = 0.007). This association was only present among individuals with high antibody responses to FliC (OR: 2.42, 95% CI: 1.45-4.06). In conclusion, our findings suggest that colorectal tumorigenesis could be accompanied by an impaired integrity of the epithelium that could result in associated increased antibody responses to bacterial proteins.
Repisalud
Publication Artículo científico (JournalArticle)

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Palazuelos, Camilo
  • Perez-Gomez, Beatriz
  • Lope Carvajal, Virginia
  • Tusquets, Ignasi
  • Alonso, María Henar
  • Moreno, Victor
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Barricarte, Aurelio
  • Tardón, Adonina
  • Camacho, Antonio
  • Peiró-Pérez, Rosana
  • Marcos-Gragera, Rafael
  • Muñoz, Montse
  • Michelena-Echeveste, Maria Jesus
  • Ortega Valin, Luis
  • Guevara, Marcela
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
INTRODUCTION: The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. METHODS: In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. RESULTS: The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI ≥ 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+ cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. CONCLUSIONS: In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).
Repisalud
Publication Artículo científico (JournalArticle)

Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study

  • Ibáñez-Sanz, Gemma
  • Díez-Villanueva, Anna
  • Alonso, María Henar
  • Rodríguez-Moranta, Francisco
  • Perez-Gomez, Beatriz
  • Bustamante, Mariona
  • Martín, Vicente
  • Llorca, Javier
  • Amiano, Pilar
  • Ardanaz, Eva
  • Tardón, Adonina
  • Jimenez-Moleon, Jose J.
  • Peiró, Rosana
  • Alguacil, Juan
  • Navarro Rivas, Carmen
  • Guinó, Elisabet
  • Binefa, Gemma
  • Fernandez-Navarro, Pablo L
  • Espinosa, Anna
  • Dávila-Batista, Verónica
  • Molina, Antonio José
  • Palazuelos, Camilo
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Moreno, Victor
  • Pollan-Santamaria, Marina
Colorectal cancer (CRC) screening of the average risk population is only indicated according to age. We aim to elaborate a model to stratify the risk of CRC by incorporating environmental data and single nucleotide polymorphisms (SNP). The MCC-Spain case-control study included 1336 CRC cases and 2744 controls. Subjects were interviewed on lifestyle factors, family and medical history. Twenty-one CRC susceptibility SNPs were genotyped. The environmental risk model, which included alcohol consumption, obesity, physical activity, red meat and vegetable consumption, and nonsteroidal anti-inflammatory drug use, contributed to CRC with an average per factor OR of 1.36 (95% CI 1.27 to 1.45). Family history of CRC contributed an OR of 2.25 (95% CI 1.87 to 2.72), and each additional SNP contributed an OR of 1.07 (95% CI 1.04 to 1.10). The risk of subjects with more than 25 risk alleles (5th quintile) was 82% higher (OR 1.82, 95% CI 1.11 to 2.98) than subjects with less than 19 alleles (1st quintile). This risk model, with an AUROC curve of 0.63 (95% CI 0.60 to 0.66), could be useful to stratify individuals. Environmental factors had more weight than the genetic score, which should be considered to encourage patients to achieve a healthier lifestyle.
Repisalud
Publication Artículo científico (JournalArticle)

Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study

  • Alonso-Molero, Jéssica
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Fernandez de Larrea-Baz, Nerea
  • Guevara, Marcela
  • Amiano, Pilar
  • Castaño-Vinyals, Gemma
  • Fernández-Villa, Tania
  • Moreno, Victor
  • Bayo, Juan
  • Molina-Barceló, Ana
  • Fernández-Ortíz, María
  • Suarez-Calleja, Claudia
  • Marcos-Gragera, Rafael
  • Castells, Xavier
  • Gil-Majuelo, Leire
  • Ardanaz, Eva
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
Breast cancer is the most frequent cause of tumors and net survival is increasing. Achieving a higher survival probability reinforces the importance of studying health-related quality of life (HR-QoL). The main aim of this work is to test the relationship between different sociodemographic, clinical and tumor-intrinsic characteristics, and treatment received with HR-QoL measured using SF-12 and the FACT/NCCN (National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy) Breast Symptom Index (FBSI). Women with breast cancer recruited between 2008 and 2013 and followed-up until 2017-2018 in a prospective cohort answered two HR-QoL surveys: the SF-12 and FBSI. The scores obtained were related to woman and tumor characteristics using linear regression models. The telephone survey was answered by 1078 women out of 1685 with medical record follow-up (64%). Increases in all three HR-QoL scores were associated with higher educational level. The score differences between women with university qualifications and women with no schooling were 5.43 for PCS-12, 6.13 for MCS-12 and 4.29 for FBSI. Histological grade at diagnosis and recurrence in the follow-up displayed a significant association with mental and physical HR-QoL, respectively. First-line treatment received was not associated with HR-QoL scores. On the other hand, most tumor characteristics were not associated with HR-QoL. As breast cancer survival is improving, further studies are needed to ascertain if these differences still hold in the long run.
Repisalud
Publication Artículo científico (JournalArticle)

Association of diabetes and diabetes treatment with incidence of breast cancer

  • García-Esquinas, Esther
  • Guinó, Elisabeth
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Llorca, Javier
  • Altzibar, Jone M
  • Peiró-Pérez, Rosana
  • Martín, Vicente
  • Moreno-Iribas, Concepción
  • Tardón, Adonina
  • Caballero, Francisco Javier
  • Puig-Vives, Montserrat
  • Guevara, Marcela
  • Fernández-Villa, Tania
  • Salas, Dolores
  • Amiano, Pilar
  • Dierssen-Sotos, Trinidad
  • Pastor-Barriuso, Roberto
  • Sala, María
  • Kogevinas, Manolis
  • Aragones, Nuria
  • Moreno, Victor
  • Pollan-Santamaria, Marina
AIMS: The aim of this study was to evaluate the association of diabetes and diabetes treatment with risk of postmenopausal breast cancer. METHODS: Histologically confirmed incident cases of postmenopausal breast (N = 916) cancer were recruited from 23 Spanish public hospitals. Population-based controls (N = 1094) were randomly selected from primary care center lists within the catchment areas of the participant hospitals. ORs (95 % CI) were estimated using mixed-effects logistic regression models, using the recruitment center as a random effect term. Breast tumors were classified into hormone receptor positive (ER+ or PR+), HER2+ and triple negative (TN). RESULTS: Diabetes was not associated with the overall risk of breast cancer (OR 1.09; 95 % CI 0.82-1.45), and it was only linked to the risk of developing TN tumors: Among 91 women with TN tumors, 18.7 % were diabetic, while the corresponding figure among controls was 9.9 % (OR 2.25; 95 % CI 1.22-4.15). Regarding treatment, results showed that insulin use was more prevalent among diabetic cases (2.5 %) as compared to diabetic controls (0.7 %); OR 2.98; 95 % CI 1.26-7.01. They also showed that, among diabetics, the risk of developing HR+/HER2- tumors decreased with longer metformin use (ORper year 0.89; 95 % CI 0.81-0.99; based on 24 cases and 43 controls). CONCLUSION: This study reinforces the need to correctly classify breast cancers when studying their association with diabetes. Given the low survival rates in women diagnosed with TN breast tumors and the potential impact of diabetes control on breast cancer prevention, more studies are needed to better characterize this association.
Repisalud
Publication Artículo científico (JournalArticle)

Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study

  • Vitelli-Storelli, Facundo
  • Molina, Antonio José
  • Zamora-Ros, Raúl
  • Fernández-Villa, Tania
  • Roussou, Vasiliki
  • Romaguera, Dora
  • Aragones, Nuria
  • Obón-Santacana, Mireia
  • Guevara, Marcela
  • Gómez-Acebo, Inés
  • Fernández-Tardón, Guillermo
  • Molina-Barceló, Ana
  • Olmedo-Requena, Rocío
  • Capelo, Rocío
  • Chirlaque, María-Dolores
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Castilla Catalán, Jesús
  • Rubín-García, María
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Lera, Juan Pablo Barrio
  • Martín, Vicente
Several epidemiological studies have investigated the association between the dietary flavonoid intake and gastric cancer (GC) risk; however, the results remain inconclusive. Investigating the relationship between the different classes of flavonoids and the histological types and origin of GC can be of interest to the research community. We used data from a population-based multi-case control study (MCC-Spain) obtained from 12 different regions of Spain. 2700 controls and 329 GC cases were included in this study. Odds ratios (ORs) were calculated using the mixed effects logistic regression considering quartiles of flavonoid intakes and log2. Flavonoid intake was associated with a lower GC risk (ORlog2 = 0.76; 95% CI = 0.65-0.89; ORq4vsq1 = 0.60; 95%CI = 0.40-0.89; ptrend = 0.007). Inverse and statistically significant associations were observed with anthocyanidins, chalcones, dihydroflavonols and flavan-3-ols. The isoflavanoid intake was positively associated with higher cancer risk, but without reaching a statistical significance. In general, no differences were observed in the GC risk according to the location and histological type. The flavonoid intake seems to be a protective factor against GC within the MCC-study. This effect may vary depending on the flavonoid class but not by the histological type and location of the tumor. Broader studies with larger sample size and greater geographical variability are necessary.
Repisalud
Publication Artículo científico (JournalArticle)

The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis

  • Alonso-Molero, Jéssica
  • González-Donquiles, Carmen
  • Palazuelos, Camilo
  • Fernández-Villa, Tania
  • Ramos, Elena
  • Pollan-Santamaria, Marina
  • Aragones, Nuria
  • Llorca, Javier
  • Henar Alonso, M.
  • Tardón, Adonina
  • Amiano, Pilar
  • Jimenez-Moleon, Jose J.
  • Peiró Pérez, Rosana
  • Capelo, Rocío
  • Molina, Antonio J
  • Acebo, Ines Gomez
  • Guevara, Marcela
  • Perez-Gomez, Beatriz
  • Lope Carvajal, Virginia
  • Huerta, José María
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • Moreno, Victor
  • Martín, Vicente
BACKGROUND: The objective of our investigation is to study the relationship between the rs4939827 SNP in the SMAD7 gene, Mediterranean diet pattern and the risk of colorectal cancer. METHODS: We examined 1087 cases of colorectal cancer and 2409 population controls with available DNA samples from the MCC-Spain study, 2008-2012. Descriptive statistical analyses, and multivariate logistic mixed models were performed. The potential synergistic effect of rs4939827 and the Mediterranean diet pattern was evaluated with logistic regression in different strata of of adherence to the Mediterranean diet and the genotype. RESULTS: High adherence to Mediterrenean diet was statistically significantly associated with colorectal cancer risk. A decreased risk for CRC cancer was observed for the CC compared to the TT genotype (OR = 0.65 and 95% CI = 0.51-0.81) of the rs4939827 SNP Also, we could show an association between the Mediterranean diet pattern (protective factor) and rs4939827. Although the decreased risk for the CC genotype was slightly more pronounced in subjects with high adherence to Mediterrenean diet, there was no statistically significant synergistic effect between genotype CC and adherence to the Mediterranean dietary pattern factors. CONCLUSION: The SMAD7 gene and specifically the allele C could be protective for colorectal cancer. An independent protective association was also observed between high adherence Mediterranean diet pattern and CRC risk. Findings form this study indicate that high adherence to Mediterranean diet pattern has a protective role for CRC cancer probably involving the Tumor Growth Factor- β pathway in this cancer.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Oxidative stress-triggered nuclear WRAP53 translocation promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Bolaños, Juan P.
  • Almeida, Angeles
Trabajo presentado en la 20th Biennial Meeting of The Society for Free Radical Research International (SFRR-I) celebrada online del 15 al 18 de marzo de 2021, Ischemic stroke is the leading cause of neurologic death and long-term adult disability worldwide. Ischemia-induced oxidative stress compromises genome integrity, resulting in DNA damage. Failure of neurons to efficiently repair DNA double-strands breaks (DSB) contributes to cerebral damage and impairs functional recovery after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder remains unknown. Here we describe that WRAP53 (WD40 encoding RNA Antisense to p53), a scaffold protein implicated in telomere elongation and DNA repair in tumor cells, plays an essential role in neuronal survival after ischemia. We found that experimental ischemia, performed by oxygen and glucose deprivation (OGD), promoted oxidative stress-induced DSB in neurons. These events spatiotemporally correlated with WRAP53 upregulation and nuclear translocation to activate DSBs repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSB and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results provide a new signaling role for reactive oxygen species in the mechanism of DSB repair in neurons and unravel the role of WRAP53 to maintaining genome integrity and survival after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018), European Regional Development Fund (FEDER), Ministerio de Ciencia en Innovación (SAF2017-90794-REDT), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17 and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León), and Fundación Ramón Areces.
Docta Complutense
Publication Capítulo o parte de un libro (BookPart)

Miradores de Madrid en la cornisa del Manzanares. Espacio público, turismo, imagen y memoria urbana

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragmen

  • Esquerda-Canals, Gisela|||0000-0002-8604-1545
  • Martí Clúa, Joaquín|||0000-0002-6774-0092
  • Rivera Hernández, Geovanny
  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Villegas Hernández, Sandra|||0000-0001-8644-4304
The therapeutic potential of scFv-h3D6 has recently been shown in the 3xTg-AD mice. A clear effect on amyloid β (Aβ) oligomers and certain apolipoproteins in the brain was found, but no effect was seen in the cerebellum. Here, cellular vulnerability of the 3xTg-AD cerebellum is described for the first time, together with its protection by scFv-h3D6. Neuron depletion in the DCN was regionally variable and followed a mediolateral axis of involvement that was greatest in the fastigial nucleus, lesser in the interpositus and negligible in the dentate nucleus. A sole and low intraperitoneal dose of scFv-h3D6 protected 3xTg-AD DCN neurons from death. Further studies might provide interesting information about both the potential of scFv-h3D6 as a therapeutic agent and the role of the cerebellum in AD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease

  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • Rivera Hernández, Geovanny
  • Marin Argany, Marta
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Villegas Hernández, Sandra|||0000-0001-8644-4304
The single-chain variable fragment, scFv-h3D6, has been shown to prevent in vitro toxicity induced by the amyloid β (Aβ) peptide in neuroblastoma cell cultures by withdrawing Aβ oligomers from the amyloid pathway. Present study examined the in vivo effects of scFv-h3D6 in the triple-transgenic 3xTg-AD mouse model of Alzheimer disease. Prior to the treatment, five-month-old female animals, corresponding to early stages of the disease, showed the first behavioral and psychological symptoms of dementia -like behaviors. Cognitive deficits included long- and short-term learning and memory deficits and high swimming navigation speed. After a single intraperitoneal dose of scFv-h3D6, the swimming speed was reversed to normal levels and the learning and memory deficits were ameliorated. Brain tissues of these animals revealed a global decrease of Aβ oligomers in the cortex and olfactory bulb after treatment, but this was not seen in the hippocampus and cerebellum. In the untreated 3xTg-AD animals, we observed an increase of both apoJ and apoE concentrations in the cortex, as well as an increase of apoE in the hippocampus. Treatment significantly recovered the non-pathological levels of these apolipoproteins. Our results suggest that the benefit of scFv-h3D6 occurs at both behavioral and molecular levels.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage

  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Vilalta Saura, Anna
  • García-Berrocoso, Teresa|||0000-0001-7387-7389
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Domingues-Montanari, Sophie
  • Cuadrado Godia, Eloy
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Martinez-Saez, Elena|||0000-0001-6004-5364
  • Ortega-Aznar, Arantxa
  • Montaner, Joan|||0000-0003-4845-2279
Spontaneous intracerebral hemorrhage (ICH) represents about 15% of all strokes and is associated with high mortality rates. Our aim was to identify the gene expression changes and biological pathways altered in the brain following ICH. Twelve brain samples were obtained from four deceased patients who suffered an ICH including perihematomal tissue (PH) and the corresponding contralateral white (CW) and grey (CG) matter. Affymetrix GeneChip platform for analysis of over 47,000 transcripts was conducted. Microarray Analysis Suite 5.0 was used to process array images and the Ingenuity Pathway Analysis System was used to analyze biological mechanisms and functions of the genes. We identified 468 genes in the PH areas displaying a different expression pattern with a fold change between -3.74 and +5.16 when compared to the contralateral areas (291 overexpressed and 177 underexpressed). The top genes which appeared most significantly overexpressed in the PH areas codify for cytokines, chemokines, coagulation factors, cell growth and proliferation factors while the underexpressed codify for proteins involved in cell cycle or neurotrophins. Validation and replication studies at gene and protein level in brain samples confirmed microarray results. The genomic responses identified in this study provide valuable information about potential biomarkers and target molecules altered in the perihematomal regions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats

  • Campos Martorell, Mireia
  • Cano-Sarabia, Mary|||0000-0003-4254-8157
  • Simats Oriol, Alba|||0000-0002-0415-1135
  • Hernández Guillamón, Maria Mar
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Maspoch, Daniel|||0000-0003-1325-9161
  • Montaner, Joan|||0000-0003-4845-2279
Although the beneficial effects of statins on stroke have been widely demonstrated both in experimental studies and in clinical trials, the aim of this study is to prepare and characterize a new liposomal delivery system that encapsulates simvastatin to improve its delivery into the brain. In order to select the optimal liposome lipid composition with the highest capacity to reach the brain, male Wistar rats were submitted to sham or transitory middle cerebral arterial occlusion (MCAOt) surgery and treated (intravenous [IV]) with fluorescent-labeled liposomes with different net surface charges. Ninety minutes after the administration of liposomes, the brain, blood, liver, lungs, spleen, and kidneys were evaluated ex vivo using the Xenogen IVIS ® Spectrum imaging system to detect the load of fluorescent liposomes. In a second substudy, simvastatin was assessed upon reaching the brain, comparing free and encapsulated simvastatin (IV) administration. For this purpose, simvastatin levels in brain homogenates from sham or MCAOt rats at 2 hours or 4 hours after receiving the treatment were detected through ultra-high-protein liquid chromatography. Whereas positively charged liposomes were not detected in brain or plasma 90 minutes after their administration, neutral and negatively charged liposomes were able to reach the brain and accumulate specifically in the infarcted area. Moreover, neutral liposomes exhibited higher bioavailability in plasma 4 hours after being administered. The detection of simvastatin by ultra-high-protein liquid chromatography confirmed its ability to cross the blood-brain barrier, when administered either as a free drug or encapsulated into liposomes. This study confirms that liposome charge is critical to promote its accumulation in the brain infarct after MCAOt. Furthermore, simvastatin can be delivered after being encapsulated. Thus, simvastatin encapsulation might be a promising strategy to ensure that the drug reaches the brain, while increasing its bioavailability and reducing possible side effects.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis

  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Mancha, Fernando|||0000-0003-0310-0894
  • Macher, Hada C.
  • García-Berrocoso, Teresa|||0000-0001-7387-7389
  • Giralt, Dolors
  • Ribo, Marc|||0000-0001-9242-043X
  • Guerrero, Juan M.
  • Montaner, Joan|||0000-0003-4845-2279
Circulating cell-free DNA (cfDNA) has been described as a prognostic marker for several diseases. Its prognostic value for short-term outcome in stroke patients treated with intravenous thrombolysis remains unexplored. cfDNA was measured on admission in 54 tissue plasminogen activator (tPA)-treated patients and 15 healthy controls using a real-time quantitative polymerase chain reaction assay. Neurological outcome was assessed at 48 h. Predictors of neurological improvement were evaluated by logistic regression analysis, and the additional predictive value of cfDNA over clinical variables was determined by integrated discrimination improvement (IDI). Stroke patients presented higher baseline cfDNA than healthy controls (408.5 (179-700.5) vs. 153.5 (66.9-700.5) kilogenome-equivalents/L, p = 0.123). A trend towards lower cfDNA levels was found in patients who neurologically improved at 48 h (269.5 (143.3-680) vs. 504 (345.9-792.3) kilogenome-equivalents/L, p = 0.130). In logistic regression analysis, recanalization at 1 h and cfDNA < 302.75 kilogenome-equivalents/L was independently associated with neurological improvement after adjustment by age, gender and baseline National Institutes of Health Stroke Scale score. The addition of cfDNA to the clinical predictive model improved its discrimination (IDI = 21.2% (9.2-33.3%), p = 0.009). These data suggest that cfDNA could be a surrogate marker for monitoring tPA efficacy by the prediction of short-term neurological outcome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case- Control (MCC) Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Palazuelos, Camilo
  • Morros, Rosa|||0000-0001-6752-8748
  • Aragonés, Nuria
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Jiménez Monleón, Jose J.
  • Ruiz Cerdá, José Luis
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Ruiz-Dominguez, José Manuel
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Pollán, Marina|||0000-0002-4328-1565
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Llorca, Javier|||0000-0001-8569-861X
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio José
  • Salas Trejo, Dolores
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Lope, Virginia
  • Jimenez-Moleon, José J.
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela|||0000-0001-9242-6364
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Aragonés, Nuria
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Alguacil, Juan|||0000-0003-2703-9725
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Costas, Laura
Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. Objectives: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. Methods: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. Results: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. Conclusions: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tumour characteristics and survivorship in a cohort of breast cancer, the MCC-Spain study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos-Calderón, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Guevara, Marcela|||0000-0001-9242-6364
  • Molina de la Torre, Antonio José
  • Domingo, Laia|||0000-0003-4420-0891
  • Fernández-Ortiz, María|||0000-0003-0017-875X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Alguacil, Juan|||0000-0003-2703-9725
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Ibáñez, Josefa
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Diaz-Santos, Marian
  • Alonso, M. Henar
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Ardanaz, Eva
  • Molinuevo, Amaia
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased The online version of this article (10.1007/s10549-020-05600-x) contains supplementary material, which is available to authorised users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)

  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Espinosa, Ana|||0000-0001-7399-3267
  • Castelló, Adela|||0000-0002-1308-9927
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Guevara, Marcela|||0000-0001-9242-6364
  • Martín, Vicente|||0000-0003-0552-2804
  • Amiano, Pilar
  • Alguacil, Juan|||0000-0003-2703-9725
  • Peiro, Rosana
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Costas, Laura
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Jimenez, Jose Juan
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Llorca, Javier|||0000-0001-8569-861X
  • Moreno-Iribas, Conchi|||0000-0001-6537-0131
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Oribe, Madalen
  • Aragonés, Nuria
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Romaguera, Dora|||0000-0002-5762-8558
Modern life involves mistimed sleeping and eating patterns that in experimental studies are associated with adverse health effects. We assessed whether timing of meals is associated with breast and prostate cancer risk taking into account lifestyle and chronotype, a characteristic correlating with preference for morning or evening activity. We conducted a population-based case-control study in Spain, 2008-2013. In this analysis we included 621 cases of prostate and 1,205 of breast cancer and 872 male and 1,321 female population controls who had never worked night shift. Subjects were interviewed on timing of meals, sleep and chronotype and completed a Food Frequency Questionaire. Adherence to the World Cancer Research Fund/American Institute of Cancer Research recommendations for cancer prevention was examined. Compared with subjects sleeping immediately after supper, those sleeping two or more hours after supper had a 20% reduction in cancer risk for breast and prostate cancer combined (adjusted Odds Ratio [OR] = 0.80, 95%CI 0.67-0.96) and in each cancer individually (prostate cancer OR = 0.74, 0.55-0.99; breast cancer OR = 0.84, 0.67-1.06). A similar protection was observed in subjects having supper before 9 pm compared with supper after 10 pm. The effect of longer supper-sleep interval was more pronounced among subjects adhering to cancer prevention recommendations (OR both cancers= 0.65, 0.44-0.97) and in morning types (OR both cancers = 0.66, 0.49-0.90). Adherence to diurnal eating patterns and specifically a long interval between last meal and sleep are associated with a lower cancer risk, stressing the importance of evaluating timing in studies on diet and cancer. What's new? Evidence shows that long-term disruption of endogenous circadian rhythms may be associated with cancer. The effects of mistimed sleeping and eating patterns that come with modern life are however less clear. This large Spanish population-based study examined whether meal timing and sleep patterns are associated with the two most common nightshift-related cancers. Adherence to a more diurnal eating pattern, and specifically an early supper and a long interval between last meal and sleep were associated with a lower breast and prostate cancer risk, stressing the importance of evaluating circadian rhythms in diet and cancer studies and revisiting recommendations for prevention.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The genomics of ecological flexibility, large brains,and long lives in capuchin monkeys revealedwith fecalFACS

  • Orkin, Joseph|||0000-0001-6922-2072
  • Montague, Michael|||0000-0003-0253-4404
  • Tejada-Martinez, Daniela|||0000-0001-9531-5280
  • de Manuel, Marc|||0000-0002-1245-0127
  • Del Campo, Javier
  • Cheves Hernandez, Saul
  • Di Fiore, Anthony|||0000-0001-8893-9052
  • Fontsere, Claudia|||0000-0003-2233-6026
  • Hodgson, Jason A.|||0000-0002-3849-2245
  • Janiak, Mareike|||0000-0002-7759-2556
  • Kuderna, Lukas F. K.|||0000-0002-9992-9295
  • Lizano, Esther|||0000-0003-3304-9807
  • Martino, Maria Pia
  • Niimura, Yoshihito|||0000-0001-7010-2537
  • Perry, George|||0000-0003-4527-3806
  • Soto Valverde, Carmen|||0000-0001-9506-5429
  • Tanga, Jia|||0000-0002-6374-0036
  • Warren, Wesley|||0000-0003-2255-2730
  • de Magalhaes, Joao Pedro|||0000-0002-6363-2465
  • Kawamura, Shoji|||0000-0003-0350-6050
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Krawetz, Roman|||0000-0002-2576-4504
  • Melin, Amanda D.|||0000-0002-0612-2514
Ecological flexibility, extended lifespans, and large brains have long intrigued evolutionary biologists, and comparative genomics offers an efficient and effective tool for generating new insights into the evolution of such traits. Studies of capuchin monkeys are particularly well situated to shed light on the selective pressures and genetic underpinnings of local adaptation to diverse habitats, longevity, and brain development. Distributed widely across Central and South America, they are inventive and extractive foragers, known for their sensorimotor intelligence. Capuchins have among the largest relative brain size of any monkey and a lifespan that exceeds 50 y, despite their small (3 to 5 kg) body size. We assemble and annotate a de novo reference genome for Cebus imitator Through high-depth sequencing of DNA derived from blood, various tissues, and feces via fluorescence-activated cell sorting (fecalFACS) to isolate monkey epithelial cells, we compared genomes of capuchin populations from tropical dry forests and lowland rainforests and identified population divergence in genes involved in water balance, kidney function, and metabolism. Through a comparative genomics approach spanning a wide diversity of mammals, we identified genes under positive selection associated with longevity and brain development. Additionally, we provide a technological advancement in the use of noninvasive genomics for studies of free-ranging mammals. Our intra- and interspecific comparative study of capuchin genomics provides insights into processes underlying local adaptation to diverse and physiologically challenging environments, as well as the molecular basis of brain evolution and longevity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dietary Constituents, Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Gutiérrez-Ruiz, Nuria
  • Aragonés, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela|||0000-0001-9242-6364
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Alguacil, Juan|||0000-0003-2703-9725
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Canseco Fernandez, Rosario
  • Castilla, Jesus|||0000-0002-6396-7265
  • Molinuevo, Amaia
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m 2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p -trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validating a breast cancer score in Spanish women. The MCC-Spain study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Palazuelos, Camilo
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Altzibar, Jone M.
  • González-Donquiles, Carmen
  • Ardanaz, Eva
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Vidal, Carmen|||0000-0003-2768-2710
  • Bayo-Calero, Juan
  • Tardón, Adonina|||0000-0001-5150-1209
  • Salas, Dolores|||0000-0003-0064-1222
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Morros, Rosa|||0000-0001-6752-8748
  • Rodriguez-Cundin, Paz
  • Vinyals, Gemma Castaño
  • Ederra, María
  • Vilorio-Marqués, Laura
  • Amiano, Pilar
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population, The MCC-Spain Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Lope, Virginia
  • Tusquets, Ignasi
  • Alonso, María Henar
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Camacho, Antonio
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Muñoz, Montse
  • Michelena-Echeveste, Maria Jesus
  • Ortega Valin, Luis
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI ≥ 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+ cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer, The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • de Pedro, María
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Servitja, Sonia|||0000-0001-6988-4519
  • Morros, Rosa|||0000-0001-6752-8748
  • Amiano, Pilar
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Diaz-Santos, Marian
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Lope, Virginia
  • Gracia-Lavedan, Esther
  • Alonso, M. Henar
  • Michelena-Echeveste, Maria Jesus
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers. The online version of this article (doi:10.1186/s12885-016-2692-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rat Middle Cerebral Artery Occlusion Is Not a Suitable Model for the Study of Stroke-Induced Spontaneous Infections

  • Campos Martorell, Mireia
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Gomis Rodríguez, Javier|||0000-0001-6258-3721
  • Salat, David
  • García Bonilla, Lídia|||0000-0003-3832-0037
  • Montaner, Joan|||0000-0003-4845-2279
Infections related to stroke-induced immunodepression are an important complication causing a high rate of death in patients. Several experimental studies in mouse stroke models have described this process but it has never been tested in other species such as rats. Our study focused on the appearance of secondary systemic and pulmonary infections in ischemic rats, comparing with sham and naive animals. For that purpose, male Wistar rats were subjected to embolic middle cerebral artery occlusion (eMCAO) or to transient MCAO (tMCAO) inserting a nylon filament. Forty-eight hours after ischemia, blood and lung samples were evaluated. In eMCAO set, ischemic rats showed a significant decrease in blood-peripheral lymphocytes (naive = 58.8±18.1%, ischemic = 22.9±16.4%) together with an increase in polymorphonuclears (PMNs) (naive = 29.2±14.7%, ischemic = 71.7±19.5%), while no change in monocytes was observed. The increase in PMNs counts was positively correlated with worse neurological outcome 48 hours after eMCAO (r = 0.55, p = 0.043). However, sham animals showed similar changes in peripheral leukocytes as those seen in ischemic rats (lymphocytes: 40.1±19.7%; PMNs: 51.7±19.2%). Analysis of bacteriological lung growth showed clear differences between naive (0±0 CFU/mL; log10) and both sham (3.9±2.5 CFU/mL; log10) and ischemic (4.3±2.9 CFU/mL; log10) groups. Additionally, naive animals presented non-pathological lung histology, while both sham and ischemic showed congestion, edema or hemorrhage. Concordant results were found in the second set of animals submitted to a tMCAO. Inflammatory and infection changes in Wistar rats subjected to MCAO models may be attributed not only to the brain ischemic injury but to the surgical aggression and/or anaesthetic stress. Consequently, we suggest that stroke-induced immunodepression in ischemic experimental models should be interpreted with caution in further experimental and translational studies, at least in rat stroke models that entail cervicotomy and cranial trepanation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Factors Secreted by Endothelial Progenitor Cells Enhance Neurorepair Responses after Cerebral Ischemia in Mice

  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Morancho, Anna|||0000-0001-9059-3206
  • Navarro Sobrino, Míriam
  • Martinez-Saez, Elena|||0000-0001-6004-5364
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Lope-Piedrafita, Silvia|||0000-0002-8127-6425
  • Barceló, Verónica
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Penalba, Anna
  • García Bonilla, Lídia|||0000-0003-3832-0037
  • Montaner, Joan|||0000-0003-4845-2279
Cell therapy with endothelial progenitor cells (EPCs) has emerged as a promising strategy to regenerate the brain after stroke. Here, we aimed to investigate if treatment with EPCs or their secreted factors could potentiate angiogenesis and neurogenesis after permanent focal cerebral ischemia in a mouse model of ischemic stroke. BALB/C male mice were subjected to distal occlusion of the middle cerebral artery, and EPCs, cell-free conditioned media (CM) obtained from EPCs, or vehicle media were administered one day after ischemia. Magnetic resonance imaging (MRI) was performed at baseline to confirm that the lesions were similar between groups. Immunohistochemical and histological evaluation of the brain was performed to evaluate angio-neurogenesis and neurological outcome at two weeks. CM contained growth factors, such as VEGF, FGF-b and PDGF-bb. A significant increase in capillary density was noted in the peri-infarct areas of EPC- and CM-treated animals. Bielschowsky's staining revealed a significant increase in axonal rewiring in EPC-treated animals compared with shams, but not in CM-treated mice, in close proximity with DCX-positive migrating neuroblasts. At the functional level, post-ischemia forelimb strength was significantly improved in animals receiving EPCs or CM, but not in those receiving vehicle media. In conclusion, we demonstrate for the first time that the administration of EPC-secreted factors could become a safe and effective cell-free option to be considered in future therapeutic strategies for stroke.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Past Connectivity but Recent Inbreeding in Cross River Gorillas Determined Using Whole Genomes from Single Hairs

  • Alvarez-Estape, Marina|||0000-0001-8242-1092
  • Pawar, Harvinder|||0000-0002-3852-4999
  • Fontsere, Claudia|||0000-0003-2233-6026
  • Trujillo, Amber
  • Gunson, Jessica L.
  • Bergl, Richard A.
  • Bermejo, Magdalena
  • Linder, Joshua M.
  • McFarland, Kelley
  • Oates, John F.
  • Sunderland-Groves, Jacqueline L.
  • Orkin, Joseph|||0000-0001-6922-2072
  • Higham, James P.
  • Viaud-Martinez, Karine A.
  • Lizano, Esther|||0000-0003-3304-9807
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
The critically endangered western gorillas (Gorilla gorilla) are divided into two subspecies: the western lowland (G. g. gorilla) and the Cross River (G. g. diehli) gorilla. Given the difficulty in sampling wild great ape populations and the small estimated size of the Cross River gorilla population, only one whole genome of a Cross River gorilla has been sequenced to date, hindering the study of this subspecies at the population level. In this study, we expand the number of whole genomes available for wild western gorillas, generating 41 new genomes (25 belonging to Cross River gorillas) using single shed hairs collected from gorilla nests. By combining these genomes with publicly available wild gorilla genomes, we confirm that Cross River gorillas form three population clusters. We also found little variation in genome-wide heterozygosity among them. Our analyses reveal long runs of homozygosity (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

C-reactive protein isoforms as prognostic markers of COVID-19 severity

  • Molins, Blanca|||0000-0003-0941-9134
  • Figueras-Roca, Marc|||0000-0002-0548-0539
  • Valero, Oliver|||0000-0003-0014-9916
  • Llorenç, Víctor|||0000-0002-7375-1564
  • Romero-Vázquez, Sara|||0000-0002-2053-7230
  • Sibila, Oriol|||0000-0002-4833-6713
  • Adan Civera, Alfredo|||0000-0002-0849-8814
  • Garcia-Vidal, Carolina|||0000-0002-8915-0683
  • Soriano Viladomiu, Alex|||0000-0002-9374-0811
C-reactive protein (CRP), an active regulator of the innate immune system, has been related to COVID-19 severity. CRP is a dynamic protein undergoing conformational changes upon activation in inflammatory microenvironments between pentameric and monomeric isoforms. Although pentameric CRP is the circulating isoform routinely tested for clinical purposes, monomeric CRP shows more proinflammatory properties. Therefore, we aimed to determine the potential of monomeric CRP in serum as a biomarker of disease severity in COVID-19 patients (admission to intensive care unit [ICU] and/or in-hospital mortality). We retrospectively determined clinical and biological features as well as pentameric and monomeric CRP levels in a cohort of 97 COVID-19 patients within 72h of hospital admission. Patients with severe disease had higher levels of both pentameric and monomeric CRP. However, multivariate analysis showed increased mCRP but not pCRP to be independently associated to disease severity. Notably, mCRP levels higher than 4000 ng/mL (OR: 4.551, 95% CI: 1.329-15.58), together with number of co-morbidities, low lymphocyte count, and procalcitonin levels were independent predictors of disease severity in the multivariate model. Our results show the potential of mCRP levels as a marker of clinical severity in COVID-19 disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Activation of C-reactive protein proinflammatory phenotype in the blood retinal barrier in vitro, Implications for age-related macular degeneration

  • Romero-Vázquez, Sara|||0000-0002-2053-7230
  • Adan Civera, Alfredo|||0000-0002-0849-8814
  • Figueras-Roca, Marc|||0000-0002-0548-0539
  • Llorenç, Víctor|||0000-0002-7375-1564
  • Slevin, M.
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Badimon, Lina|||0000-0002-9162-2459
  • Dick, Andrew D.
  • Molins, Blanca|||0000-0003-0941-9134
The retinal pigment epithelium (RPE) is considered one of the main targets of age-related macular degeneration (AMD), the leading cause of irreversible vision loss among the ageing population worldwide. Persistent low grade inflammation and oxidative stress eventually lead to RPE dysfunction and disruption of the outer blood-retinal barrier (oBRB). Increased levels of circulating pentameric C-reactive protein (pCRP) are associated with higher risk of AMD. The monomeric form (mCRP) has been detected in drusen, the hallmark deposits associated with AMD, and we have found that mCRP induces oBRB disruption. However, it is unknown how mCRP is generated in the subretinal space. Using a Transwell model we found that both pCRP and mCRP can cross choroidal endothelial cells and reach the RPE in vitro and that mCRP, but not pCRP, is able to cross the RPE monolayer in ARPE-19 cells. Alternatively, mCRP can originate from the dissociation of pCRP in the surface of lipopolysaccharide-damaged RPE in both ARPE-19 and primary porcine RPE lines. In addition, we found that the proinflammatory phenotype of mCRP in the RPE depends on its topological localization. Together, our findings further support mCRP contribution to AMD progression enhancing oBRB disruption.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

New quantitative analyses of the Nacholapithecus kerioi proximal ulna confirm morphological affinities with Equatorius and large papionins

  • Pina, Marta|||0000-0001-9762-6402
  • Nakatsukasa, Masato|||0000-0002-6897-8027
Objectives: The elbow of Nacholapithecus has been extensively described qualitatively, however its ulnar morphology has never been the focus of an in-depth quantitative analysis before. Hence, our main aim is quantifying the proximal ulnar morphology in Nacholapithecus and exploring whether it is similar to those of Equatorius and Griphopithecus as previously reported. Materials and Methods: We compared Nacholapithecus proximal ulnar morphology with a sample of extant and extinct anthropoids through principal component analysis and agglomerative hierarchical cluster analysis. Moreover, we calculated the Cophenetic Correlation Coefficient and checked for taxonomical group mean differences through MANOVA and pairwise post-hoc comparisons, as well as the phylogenetic signal in the variables used. Results: The Nacholapithecus ulna displays a moderately long and relatively narrow olecranon, a relatively wide trochlear surface-radial notch width, and a relatively thin sigmoid notch depth. These features resemble those of large papionins and chimpanzees, and some extinct taxa, mainly Equatorius. Discussion: Results presented here reinforce previous inferences on the functional morphology of the Nacholapithecus elbow, showing adaptations for general quadrupedal behaviors. However, other derived features (e.g., a relatively wide trochlear surface) might be associated with the ape-like traits described for its distal humerus (e.g., wide trochlear groove), thus displaying a combination of primitive and derived features in the proximal ulna. Finally, affinities with large papionins could suggest the presence of some terrestrial habits in Nacholapithecus. However, the lack of evidence in the rest of the skeleton prevents us from suggesting terrestrial affinities in this taxon in a conclusive manner.
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Libro o Monografía (Book)

La ciudad del turismo: arquitectura, patrimonio urbano y espacio público

  • Layuno Rosas, Ángeles|||0000-0002-8802-7480
  • Chías Navarro, Pilar|||0000-0001-6686-8820
  • Calatrava, Juan
  • Barba González, José Juan|||0000-0002-0540-3613
  • Aumente Rivas, Pilar
  • Chaves Martín, Miguel Ángel
  • Pereira de Faria, Julia Cristina
  • Cabestan, Jean-François
  • Chabard, Pierre
  • Galant, Ivanne
  • Hernández Martínez, Ascensión
  • Calle Vaquero, Manuel de la
  • Goycoolea Prado, Roberto|||0000-0003-2997-0695
  • Zamudio Vega, Laura Susana
  • Coca Leicher, José de
368 p., El turismo cultural ha generado en nuestra época múltiples efectos sobre los ámbitos de la arquitectura, el patrimonio arquitectónico y urbano, y sobre el espacio público de la ciudad. Conscientes de esos impactos, con diferentes métodos de análisis y enfoques (desde la geografía urbana, la historia de la arquitectura y de la ciudad, el urbanismo, las teorías del patrimonio y la restauración), los textos que se recogen en esta monografía, reflexionan sobre diversos aspectos relacionados con la influencia de los fenómenos turísticos en ciudades como Madrid, París, Berlín, Sevilla, Oporto o Baja Ensenada (México). Las diversas contribuciones se centran en las características físicas e ideológicas de las diferentes intervenciones sobre bienes patrimoniales construidos, urbanos o paisajísticos implicados en el consumo turístico. Por otra parte, se evalúan de manera crítica los procesos y factores que intervienen no sólo en los criterios de recuperación de los bienes sino también en la construcción de la imagen y de los imaginarios que son capaces de desencadenar. Las nuevas actuaciones de modernización de la ciudad, la apropiación de memorias selectivas frente a la densidad histórica de los lugares, o la aparición de singulares equipamientos y espacios globales insta a la necesidad de insertar la investigación urbana y arquitectónica en las políticas de remodelación de la ciudad para usos turísticos o culturales. Esta publicación, por ello, presenta nuevas líneas de investigación aspirantes a ofrecer una visión transversal y crítica sobre nuestro entorno global modificado por las políticas y las estrategias de consumo cultural., Este volumen recoge los resultados de los siguientes proyectos de investigación: La influencia del turismo en la transformación del espacio urbano. Ficciones patrimoniales. Universidad de Alcalá y Casa de Velázquez - École des Hautes Études Hispaniques et Ibériques (2016-2018). Referencia: UAH-Casa de Velázquez (2016/00265/001); y Edificios culturales y espacio público urbano: parámetros de análisis y evaluación de los procesos generados por intervenciones urbano-arquitectónicas (2018-2019). Universidad de Alcalá (Ref. CCGP2017-EXP/035), vinculados al grupo de investigación Arquitectura, Historia, Ciudad y Paisaje-ARHCIPAI (Grupo Alto Rendimiento UAH), Universidad de Alcalá